AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)

$10.25 -0.79 (-7.1558%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 79

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) News Sources

European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading

15-06-2026

yahoo.com

Akari Therapeutics Completes Previously Announced PIPE, Strengthening Balance Sheet Ahead of Potential Key Clinical and Regulatory Milestones

29-06-2026

yahoo.com

Akari Therapeutics Appoints Former AACR President and Renowned Oncology Drug Development Leader, Patricia LoRusso, D.O., to Scientific Advisory Board

07-07-2026

yahoo.com

Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics

21-07-2026

yahoo.com

Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity

22-07-2026

yahoo.com

Akari Therapeutics Releases CEO Corner Highlighting Strategic WhiteHawk Collaboration and the Expanding Opportunity for Dual-Payload ADC Innovation

04-08-2026

yahoo.com

Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform

13-08-2026

yahoo.com

Akari Therapeutics Builds Momentum for AKTX-101 with Compelling Urothelial Cancer Data Supporting Differentiated ADC Strategy

18-08-2026

yahoo.com

Akari Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference

27-08-2026

yahoo.com

Akari Therapeutics Selected to Showcase Novel PH1 ADC Payload Platform at Leading Global Oncology, ADC and Healthcare Forums

08-09-2026

yahoo.com

AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) Sentiment Trend

0 25 50 75 100 71 77 76 84 89 84 74 79 83 77 15-06-2026 29-06-2026 07-07-2026 21-07-2026 22-07-2026 04-08-2026 13-08-2026 18-08-2026 27-08-2026 08-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) FAQs

toggle

What is the current price of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?

The current price of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is $10.25.


toggle

AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) absolute price change since previous trading day?

The absolute price change of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) since the previous trading day is $-0.79.


toggle

AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) percentage price change since previous trading day?

The percentage price change of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) since the previous trading day is -7.1558%.


toggle

What is the most recent average sentiment score for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?

The most recent average sentiment score for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is 79 out of 100.


toggle

What is the most recent average sentiment for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?

The most recent sentiment for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is .


SEC-8K** Filing Available For AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.